市場調査レポート

商品コード

1533618

ゲノミクスの市場規模、シェア、成長分析：製品・サービス別、エンドユーザー別、研究タイプ別、地域別 - 産業予測、2024年～2031年

Genomics Market Size, Share, Growth Analysis, By Product & Service (Consumables & Reagents, Services), End User (Pharmaceutical and Biotechnology, Hospital & Clinical), By Study Type (Functional, Genomics), By Region - Industry Forecast 2024-2031

出版日: 2024年08月09日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ゲノミクスの市場規模は、2022年に278億1,000万米ドルとなり、2023年の332億5,000万米ドルから、2031年までには4,113億5,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは19.4％で成長する見通しです。

ゲノミクスは、生物のDNAの構造、機能、進化、マッピングに焦点を当てたゲノムの研究です。この分野は人間の生活に大きな影響を与え、ゲノミクス革命による医学と生物医学の急速な変革を促しています。世界のがん罹患率の上昇により、ゲノミクスプロジェクトに対する助成金による政府支援が増加しています。ヒトゲノムの研究によって可能になった個別化医療の概念は、臨床腫瘍学と希少遺伝性疾患の治療に革命をもたらしました。学術界では、遺伝学と認知障害との関連性を研究し、これらの症状における脳の役割をより深く理解する動きが加速しています。ゲノミクス市場は、がんおよびがん治療に関する研究の拡大、迅速でわかりやすい臨床診断に対する需要の高まり、政府機関およびバイオ製薬企業による研究開発への投資の増加により、急速な収益成長を遂げています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Illumina, Inc.（US）
Thermo Fisher Scientific（US）
Qiagen N.V.（Netherlands）
BGI Group（China）
F. Hoffmann-La Roche AG（Switzerland）
Danaher Corporation（US）
Pacific Biosciences of California, Inc.（US）
Oxford Nanopore Technologies, Ltd.（United Kingdom）
Agilent Technologies, Inc.（US）
Eurofins Scientific SE（Luxembourg）
Bio-Rad Laboratories, Inc.（US）
Myriad Genetics, Inc.（US）
Fluidigm Corporation（US）
PerkinElmer, Inc.（US）
Twist Bioscience Corporation（US）
Natera, Inc.（US）
Veracyte, Inc.（US）
Personalis, Inc.（US）
10x Genomics, Inc.（US）
Quest Diagnostics（US）

Product Code: SQMIG35H2173

Genomics Market size was valued at USD 27.81 billion in 2022 and is poised to grow from USD 33.25 billion in 2023 to USD 411.35 billion by 2031, growing at a CAGR of 19.4% in the forecast period (2024-2031).

Genomics involves the study of genomes, focusing on the structure, function, evolution, and mapping of an organism's DNA. This field has significantly impacted human life, driving a rapid transformation in medicine and biomedical sciences due to the genomics revolution. The rising global incidence of cancer has prompted increased government support through grants for genomics projects. The concept of personalized medicine, made possible by studying the Human Genome, has revolutionized clinical oncology and the treatment of rare genetic disorders. Academics are increasingly investigating the connection between genetics and cognitive disorders to better understand the brain's role in these conditions. The genomics market is experiencing rapid revenue growth due to the expanding research on cancer and cancer therapies, the growing demand for quick and straightforward clinical diagnoses, and the increased investment in R&D by government organizations and biopharmaceutical companies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genomics Market Segmental Analysis

The genomics market is segmented into Product & Service, Technology, Study Type, Application, End Use, and Region. Based on Product and Service, the market is segmented into Consumables and Reagents, Services, Instruments, Systems, and Software. Based on Technology, the market is segmented into Sequencing, PCR, Genomics, Microarrays, Other Technologies. Based on Study Type, the market is segmented into Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, and Other Study Types. Based on Application, the market is segmented into Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, and Other Applications. Based on End User, the market is segmented into Government and Academic Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other End Users. Based on Region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Drivers of the Global Genomics Market

The genomics market is being propelled by the expanding application of Next-Generation Sequencing (NGS) in cancer research. NGS technologies are increasingly utilized for whole-genome sequencing, genome diversity studies, metagenomics, epigenetics, non-coding RNA discovery, protein-binding site identification, and RNA sequencing for gene expression profiling. These diverse applications of NGS are significantly contributing to the growth of the genomics market.

Restraints in the Global Genomics Market

The genomics market is experiencing a growing demand for a skilled genetic workforce. However, a potential limitation is the availability of competent personnel. Additionally, the high cost of genomic equipment and challenges related to data storage for sequenced data from 2023 to 2031 are expected to impact market growth. Integrating genomic approaches and technologies into healthcare systems holds promise for enhancing safety, quality, efficiency, and cost-effectiveness. Nevertheless, achieving these benefits largely depends on the availability of skilled professionals.

Market Trends of the Global Genomics Market

Organizations using the Illumina OmniExpress chip, such as Ancestry.com, will need to transition to the customized Illumina Global Screening Array (GSA) microarray, as the OmniExpress chip will be phased out. This shift will compel these organizations to either adopt the GSA chip, switch to Thermo Fisher Scientific products, or implement next-generation sequencing technology to maintain their operations.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Start-up Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Genomics Market by Product & Service

Market Overview
Consumables and Reagents
Services
Instruments, Systems, and Software

Genomics Market by Technology

Market Overview
Sequencing
PCR
Flow Cytometry
Microarrays
Other Technologies

Genomics Market by Application

Market Overview
Drug Discovery and Development
Diagnostics
Agriculture and Animal Research
Other Applications

Genomics Market by Study Type

Market Overview
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Other Study Types

Genomics Market by End User

Market Overview
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Other End Users

Genomics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies, Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veracyte, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Personalis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ゲノミクスの市場規模、シェア、成長分析：製品・サービス別、エンドユーザー別、研究タイプ別、地域別 - 産業予測、2024年～2031年

Genomics Market Size, Share, Growth Analysis, By Product & Service (Consumables & Reagents, Services), End User (Pharmaceutical and Biotechnology, Hospital & Clinical), By Study Type (Functional, Genomics), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

ゲノミクス市場：製品・サービス別

ゲノミクス市場：技術別

ゲノミクス市場：用途別

ゲノミクス市場：研究タイプ別

ゲノミクス市場：エンドユーザー別

ゲノミクス市場規模：地域別